Desmopressin (DDAVP)
![](https://elearning.wfh.org/wp-content/uploads/2016/07/1648-img.jpg)
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Polish Desmopressin (DDAVP) may be the treatment of choice for patients with mild or moderate hemophilia A and type 1 von Willebrand disease (VWD). This Fact Sheet presents essential information about this synthetic medicine which costs much less than […]
Desmopressin (DDAVP) – Polish
![](https://elearning.wfh.org/wp-content/uploads/2018/09/1687-img.jpg)
Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese This is not an official WFH translation. This resource has been translated with permission by a WFH National Member Organization (NMO), and is shared here with their kind permission. Translating organizations are encouraged to have translations reviewed by local experts, the WFH is not responsible for […]
Delivery of Treatment for Haemophilia: Report of a Joint WHO/WFH/ISTH Meeting
![](https://elearning.wfh.org/wp-content/uploads/2002/07/1451-img.jpg)
Helps identify effective treatment strategies for hemophilia. Topics include delivery of treatment, on-demand treatment, prophylaxis, immune tolerance, and factor assays.
Control of Haemophilia: Haemophilia Care in Developing Countries Report of a joint WHO/WFH Meeting
![](https://elearning.wfh.org/wp-content/uploads/1997/07/1452-img.jpg)
This joint WFH/WHO report outlines the possibilities and priorities for hemophilia care delivery in the developing world
Guidelines for the Development of a National Programme for Haemophilia
![](https://elearning.wfh.org/wp-content/uploads/1996/07/1445-img.jpg)
Jointly produced by the WFH and WHO, this publication provides guidance on the development of a successful national care program for hemophilia.
Report of a joint WHO/WFH Meeting on the control of haemophilia: Modern Treatment of Haemophilia
![](https://elearning.wfh.org/wp-content/uploads/1994/07/1453-img.jpg)
This joint WFH/WHO report reviews those issues surrounding management of hemophilia and its complications.
Report on a joint WHO/WFH meeting on the control of haemophilia: Carrier detection and prenatal diagnosis
![](https://elearning.wfh.org/wp-content/uploads/1993/07/1450-img.jpg)
Updates the 1977 WHO/WFH Memorandum on Methods for the Detection of Haemophilia Carriers, in view of the recent explosive development of DNA technology and their continuing simplification.
Prevention and Control of Haemophilia: Memorandum from a Joint WHO/WFH Meeting
![](https://elearning.wfh.org/wp-content/uploads/1990/07/1449-img.jpg)
Summarizes discussions and recommendations for the prevention and control of hemophilia made by participants at a joint WHO/WFH Meeting.